Today AIMT ranks # as SELL CANDIDATE.
Today AIMT ranks # as SELL CANDIDATE.

AIMT stock Aimmune Therapeutics

AIMT stock
Aimmune Therapeutics

22 January 2019
Change 0.00%
Chart period: 2018-10-23 - 2019-01-22




Request Prediction

Aimmune Therapeutics Stock Analysis

Technical stock analysis for 22 January 2019

Sell candidate since 2019-01-14 Loss -5.76%
Shorts n/a
Cash 182.4 mill
Loans n/a
Beta -0.18
ROA -74.81

No changes to the price of Aimmune Therapeutics in the last trading day. The price has fallen in 5 of the last 10 days and is down by -9.05% for this period.

Close price at the end of the last trading day (Tuesday, 22nd Jan 2019) of the AIMT stock was $22.90.

During day the stock fluctuated 0.00% from a day low at $22.90 to a day high of $22.90.

30 day high of the AIMT stock price was $26.68 and low was $21.85.
90 day high was $36.12 and low was $21.38.
52 week high for the Aimmune Therapeutics - $42.00 and low - $21.38.


Aimmune Therapeutics lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -17.23% during the next 3 months and, with 90% probability hold a price between $16.08 and $22.76 at the end of this period.

Click here for today's Top 5 Trending Companies


A buy signal was issued from a pivot bottom point on Thursday January 17, 2019, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Aimmune Therapeutics holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $23.65 and $23.66. A break-up above any of these levels will issue buy signals. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 44 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Aimmune Therapeutics finds support from accumulated volume at $22.75.

Support: $22.75 Price: $22.90 Resistance: $23.73


This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.00 between high and low, or 0.00%. For the last week the stock has had a daily average volatility of 5.44%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High


Aimmune Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Today AIMT ranks # as SELL CANDIDATE.
Today AIMT ranks # as SELL CANDIDATE.